Basal-like breast cancers overlap to a large degree with clinically defined triple-negative tumours (ER-negative, PR-negative and HER2-negative), whilst Luminal A/B and HER2 correspond respectively to ER negative and ER-negative/HER2-positive tumours. This evidence concerns the gene ERBB2 and breast carcinoma.